Innovative Tools for Digital Pathology: Automated ROI Detection and Image Patch Extraction
Read more
Clinical Services
Onboard your clinical NGS test with our team, ensuring your test meets regulatory and reimbursement requirements and that the assay meets your patient population needs.
Service Overview
Laboratories encounter numerous challenges in launching new tests, integrating systems, and maintaining compliance with evolving regulations. The complexities of validation, ensuring compatibility with existing EMRs, and navigating reimbursement procedures can create bottlenecks that delay patient results and disrupt operational efficiency.
Having spent 10+ years partnering with labs to start up their testing programs we have learned what it takes to be able to get going quickly. Our clinical services help you get up and running while our CGW software make it easy and efficient to scale your operation.
We offer the following services to labs:
Why use Velsera’s Clinical services
Better
Velsera’s end-to-end laboratory support enhances the quality and precision of your workflows. From customized reports for patients and oncologists to expert guidance on SOP development, we ensure your lab delivers accurate, high-quality care with confidence.
Faster
Streamline your lab’s operations with optimized software configuration, API and HL7 integrations, and EMR connectivity. These solutions enable faster turnaround times and more efficient delivery of results to patients and clinicians.
Simpler
Simplify regulatory complexities with concierge services that cover CAP/CLIA validations, MolDX approvals, and audit readiness. Our expert team ensures your lab achieves compliance while improving workflows for greater operational impact.
Who we help accelerate
Clinical Diagnostic Laboratories
Grow revenue by expanding your NGS business. Velsera helps diagnostic labs rapidly establish and grow new, profitable NGS revenue streams. With our support, we can help your lab get up-and-running with an existing on-market assay (20+ LDT & IVD options available), including support for validation, revenue cycle management, and our Clinical Genomics Workspace (CGW) software to aid clinical decision-making.
NGS Assay & Equipment Manufacturers
Have you got a promising diagnostic test in development? Or do you have novel equipment that you want to drive uptake of in the clinical setting? Velsera can partner with you to bring new, promising tests to market by creating, integrating, hosting and/or deploying custom-developed NGS analysis pipelines. Additionally, we can help your future laboratory customers with validation and regulatory support to ensure compliance, as well as Revenue Cycle Management support to enable reimbursement – increasing the uptake.
Biotech & Pharma
Don’t wait until the last minute to design and develop your Companion Diagnostic (CDx) – it literally is the rate limiting gate keeper to scaling your new therapy! Velsera can partner with you to design and develop your test by creating, integrating, hosting and/or deploying custom-developed NGS analysis pipelines. Additionally, once live in the market, we can help labs with validation and regulatory support to ensure compliance, as well as Revenue Cycle Management support to enable reimbursement – increasing the uptake from customers. Optionally, tertiary CGW reporting is available to create a fully integrated secondary & tertiary analysis package for your test.
Solutions
Clinical Interpretation & Reporting
Grow revenue by expanding your NGS business. Velsera helps diagnostic labs rapidly establish and grow new, profitable NGS revenue streams. With our support, we can help your lab get up-and-running with an existing on-market assay (20+ LDT & IVD options available), including support for validation, revenue cycle management, and our Clinical Genomics Workspace (CGW) software to aid clinical decision-making.
NGS Assay Development & Expansion
Has your lab recognized an unmet need in the market? Velsera helps ambitious diagnostic labs generate revenue by creating, integrating, hosting and/or deploying custom-developed NGS analysis pipelines. Additionally, we help with validation and regulatory support to ensure compliance, as well as Revenue Cycle Management support to enable reimbursement. Optionally, tertiary CGW reporting is available to create a fully integrated secondary & tertiary analysis package for your test.
IVD Compliance Transition
Don’t let compliance challenges impede your progress. Velsera assists labs in navigating the FDA clearance process for both new assays and existing Laboratory Developed Tests (LDTs). We provide the necessary “dry-lab” component for approved products, along with optional tertiary reporting to enhance your workflow.
Companion Diagnostic Development & Scaling
Don’t wait until the last minute to design and develop your Companion Diagnostic (CDx) – it literally is the rate limiting gate keeper to scaling your new therapy! Velsera can partner with you to design and develop your test by creating, integrating, hosting and/or deploying custom-developed NGS analysis pipelines. Additionally, once live in the market, we can help labs with validation and regulatory support to ensure compliance, as well as Revenue Cycle Management support to enable reimbursement – increasing the uptake from customers. Optionally, tertiary CGW reporting is available to create a fully integrated secondary & tertiary analysis package for your test.
Real-world impact, trusted partnerships
“Velsera has been a great partner enabling our NGS offering so we can improve the quality and speed of patient care. With Velsera's team and technology, we have been able to streamline our workflow and customize our clinical report. We can run various assays using the single Velsera platform. And our physicians are highly complementary of the report we created with Velsera given the content and aesthetic.”
Blog
On December 12, 2024 | By Jovan Babic
Read more
Blog
On October 29, 2024 | By Christopher Wilkinson
Read more
Blog
On October 10, 2024 | By Cates Mallaney
Read more
News
On October 8, 2024 | By The Velsera Clinical and Compliance Team
Read more
Reach out to us, and we’ll get back to you quickly!